Jhonatan R Mejia

Datos Biográficos

ID7985231
NOMBREJhonatan R Mejia
NOMBRESJhonatan R
APELLIDOMejia
FIRMAMEJIA J R
AFILIACIONESInstituto de Efectividad Clínica y Sanitaria
ORCID0000-0002-9846-8503
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
OBRAS COMO AUTOR2
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures

    Open AccessAriel Bardach, Andrea Alcaraz et al.ARTICLERevista Peruana de Medicina…2025

    Motivation for the study. Despite progress in tobacco control, the economic and disease burden in Peru remains high. Strengthening smoke-free regulations, implementing plain packaging, banning tobacco promotion and sponsorship, and increasing taxes could reduce it. Main findings. Tobacco use causes 22,350 deaths and 126,000 disease events annually in Peru, resulting in a loss of 1.28% of GDP. Strengthening tobacco control policies would prevent t…

  • Uso de medicamentos en pacientes pediátricos con Covid-19 hospitalizados en un hospital de referencia de Lima, Perú

    Open AccessMedalit Luna-Vílchez, Jhonatan R Mejia et al.ARTICLERevista Peruana de Medicina…2023

    Motivation for the study. Therapeutic guidelines for COVID-19 in children changed constantly during the pandemic. In Peru, the variation of the treatment during the different waves of the pandemic has not been studied. Main findings. During the third wave, there was a greater number of patients with COVID-19; however, these patients had less severe symptoms. The use of ceftriaxone and azithromycin was less frequent during the third wave. The use …